Chahal P, Fallon T J, Jennings S J, Chowienczyk P J, Kohner E M
Diabetes Care. 1986 Mar-Apr;9(2):134-9. doi: 10.2337/diacare.9.2.134.
Vitreous fluorophotometry was used to estimate fluorescein leakage into the posterior vitreous of 20 insulin-dependent diabetic patients with no or minimal diabetic retinopathy 60 min after intravenous administration of 14 mg X kg-1 fluorescein. The permeability coefficient (p), a measure of fluorescein penetration through the blood-retinal barrier (BRB) into the vitreous, and the diffusion coefficient (D), a measure of fluorescein dispersion within the vitreous, were obtained by fitting a mathematical model to the vitreous fluorescence scan and plasma free fluorescence curve. A permeability index (PI) was also derived by dividing the area under the fluorescence scan by the area under the plasma free fluorescence time curve. The fluorescence concentrations at discrete distances from the retina were also noted. The mean +/- SD for p, D, and PI were 1.95 +/- 1.03 cm X s-1 X 10(-7), 1.74 +/- 1.53 cm2 X s-1 X 10(-5), and 2.14 +/- 1.21 cm X s-1 X 10(-7), respectively, and were not significantly different from values determined in normal subjects. Diabetic patients and normal subjects also had similar fluorescence measurements at corresponding distances from the retina. Quantitative indices of fluorescein leakage did not correlate with either the microaneurysm counts on fluorescein angiograms or the duration of diabetes. Vitreous fluorophotometry did not detect any abnormality of the BRB in diabetic patients with no or minimal retinopathy on fluorescein angiography.
对20名胰岛素依赖型糖尿病患者静脉注射14mg/kg荧光素60分钟后,采用玻璃体荧光光度测定法评估荧光素向无糖尿病视网膜病变或仅有轻微病变的患者的玻璃体后部渗漏情况。通过将数学模型拟合到玻璃体荧光扫描和血浆游离荧光曲线,获得了通透性系数(p),即荧光素透过血视网膜屏障(BRB)进入玻璃体的量度,以及扩散系数(D),即荧光素在玻璃体内扩散的量度。还通过将荧光扫描下的面积除以血浆游离荧光时间曲线下的面积得出通透性指数(PI)。同时记录了距视网膜不同距离处的荧光浓度。p、D和PI的平均值±标准差分别为1.95±1.03cm·s-1×10-7、1.74±1.53cm2·s-1×10-5和2.14±1.21cm·s-1×10-7,与正常受试者测定的值无显著差异。糖尿病患者和正常受试者在距视网膜相应距离处的荧光测量结果也相似。荧光素渗漏的定量指标与荧光素血管造影上的微动脉瘤计数或糖尿病病程均无相关性。玻璃体荧光光度测定法未在荧光素血管造影显示无或仅有轻微视网膜病变的糖尿病患者中检测到BRB的任何异常。